Tag Archives: WeightLoss

New research has discovered certain weight-loss medications could be associated with an increased risk of serious eye conditions, and even vision loss. Two studies, published in JAMA, analyzed how semaglutide and tirzepatide — which include popular drugs like Ozempic, Wegovy, Mounjaro and Zepbound — impacted eye health in Americans with type 2 diabetes over a two-year period. One study found …

Lilly to hike UK price of Mounjaro weight-loss drug by 170%  Reuters Lilly raises UK obesity shot price as Trump pressures pharma  Yahoo Finance Eli Lilly says it will raise drug prices in Europe to ‘make them lower’ in U.S.  statnews.com Lilly Hikes UK Obesity Shot Price as Trump Pressures Drugmakers  Bloomberg.com Eli Lilly hikes price of diabetes drug Mounjaro in UK as Trump …

Weight-loss jabs have become a national obsession, it seems. More than one in five UK adults tried to access weight-loss medications in the past year alone, according to a survey by the National Pharmacy Association. This rises to more than one in three (35 per cent) of those aged under 35. The soaring demand is because these revolutionary medications can …

Drugs such as Ozempic, Wegovy and Mounjaro (known as semaglutide and tirzepatide) have changed the way clinicians manage diabetes and obesity around the world. Collectively known as GLP-1 agonists, these drugs mimic the hormone GLP-1. This limits both hunger and interest in food, helping users lose weight, and helps control blood sugar levels. But two new studies published today show …

Key Takeaways Results from a late-stage trial of Eli Lilly’s experimental weight loss pill were disappointing, sending shares of the drugmaker tumbling. The study found average weight loss from the treatment was below that of rival Novo Nordisk’s Wegovy. The news offset Lilly’s much better-than-expected quarterly results and guidance boost. Ely Lilly (LLY) shares sank 14% Thursday when the pharmaceutical …

Eli Lilly Shares Slide as Weight-Loss Pill Results Dent Enthusiasm  The Wall Street Journal Eli Lilly’s obesity pill led to around 12% weight loss in closely watched late-stage trial; shares drop  CNBC Eli Lilly’s key obesity pill falls short of rivals, but the company still beat on earnings  statnews.com Experimental GLP-1 pill helped people with obesity lose weight, Eli Lilly says  CNN Daily oral …

Hims & Hers Stock Slides on Earnings. Weight-Loss Drugs Are Just One Problem.  Barron’s Hims & Hers stock slides 5% after second quarter revenue misses forecasts  Yahoo Finance Hims & Hers stock falls 10% on revenue miss  CNBC Investing in the Future of Healthcare  Hims & Hers Newsroom IBD 50’s Hims Dives. Why It Will Remain A ‘Market Darling.’  Investor’s Business Daily Source link

US plans to test Medicare, Medicaid coverage for weight-loss drugs, Washington Post reports  Reuters Medicare, Medicaid plan to experiment with covering weight loss drugs  The Washington Post Trump officials plan coverage for weight loss drugs under Medicare and Medicaid  The Guardian Medicare, Medicaid to try coverage of GLP-1s for obesity, report says  Axios Trump’s Weight-Loss Experiment Could Aid Lilly, Novo. Cost Is Still a …

Elli Lilly Weight-Loss Drug Makes Cardio Advance. More Bad News for Novo Nordisk.  Barron’s Lilly’s Mounjaro (tirzepatide), a GIP/GLP-1 dual agonist, demonstrated cardiovascular protection in landmark head-to-head trial, reinforcing its benefit in patients with type 2 diabetes and heart disease  Eli Lilly and Company Eli Lilly’s Mounjaro shows heart health benefits in head-to-head trial with older diabetes drug Trulicity  CNBC Eli Lilly’s diabetes …

The last thing Chevese Turner needed was medication to help her lose weight. Twenty years into recovery from binge eating disorder and atypical anorexia, she was done trying to whittle her physique into something it didn’t want to be. But after developing diabetes a few years ago, her doctor prescribed Mounjaro, a glucagon-like peptide-1 receptor agonist (or GLP-1) that helps …